Learn more

SCIL PROTEINS GMBH

Overview
  • Total Patents
    105
  • GoodIP Patent Rank
    190,357
About

SCIL PROTEINS GMBH has a total of 105 patent applications. Its first patent ever was published in 1998. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are U3 PHARMA AG, 4ANTIBODY AG and NBE THERAPEUTICS LLC.

Patent filings per year

Chart showing SCIL PROTEINS GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Fiedler Markus 36
#2 Fiedler Erik 32
#3 Fiedler Ulrike 29
#4 Rudolph Rainer 27
#5 Steuernagel Arnd 25
#6 Nerkamp Joerg 21
#7 Kunert Anja 18
#8 Gloser Manja 18
#9 Goettler Thomas 15
#10 Anton Andreas 12

Latest patents

Publication Filing date Title
US2015183846A1 Human fusion proteins comprising single chain tnfalpha and targeting domains
WO2014094799A1 Ubiquitin moieties as a means for prolonging serum half-life
US2013183265A1 Mia-2 protein
EP2721056A1 Human fusion proteins comprising interferons and targeted modified ubiquitin proteins
WO2012172054A1 Modified multimeric ubiquitin proteins binding vegf-a
WO2012171541A1 Human fusion proteins comprising interferons and hetero-dimeric modified ubiquitin proteins
WO2011131491A1 Method of producing soluble recombinant protein
CA2782093A1 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin
EP2380975A1 Method for producing recombinant thrombin
EP1955712A1 Multimeric conjugate
EP1925664A1 Artificial binding proteins based on a modified alpha helical region of ubiquitin
DE102004049479A1 Protein conjugates for use in therapy, diagnosis and chromatography
DE10360483A1 Expression vector and its use
DE10324447A1 Generation of artificial binding proteins based on ubiquitin
DE10317369A1 proNGF as a pharmaceutically effective agent for the treatment of demyelinating diseases
DE10313341A1 Use of proNGF, especially for wound healing of the cornea and skin
DE10305082A1 MIA-2 protein
DE10161577A1 Process for the renaturation of proteins
DE10059336A1 Production of recombinant BMP-2
DE19932688A1 Design of beta-sheet proteins of gamma-II-crystalline antibody-like